Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 1.00 |
| ▸ | NPC1 | O15118 | 9/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.77 |
| ▸ | RAB9A | P51151 | 7/20 | 0.77 |
| ▸ | AHR | P35869 | 2/20 | 0.77 |
| ▸ | POLB | P06746 | 1/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | HPGD | P15428 | 1/20 | 0.71 |
| ▸ | CASP1 | P29466 | 2/20 | 0.68 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16794821 | 0.87 | MAPT (0.77) | MAPTNPC1KMT2ASMN1; SMN2RAB9A | |
| SCHEMBL30979841 | 0.87 | MAPT (1.00) | MAPTNPC1KMT2ASMN1; SMN2RAB9A | |
| SCHEMBL1869991 | 0.87 | NPC1 (1.00) | MAPTNPC1KMT2ASMN1; SMN2RAB9A | |
| SCHEMBL9720114 | 0.87 | MAPT (1.00) | MAPTNPC1KMT2ASMN1; SMN2RAB9A | |
| SCHEMBL30979845 | 0.87 | MAPT (1.00) | MAPTNPC1KMT2ASMN1; SMN2RAB9A | |
| SCHEMBL2774740 | 0.84 | MAPT (0.72) | MAPTNPC1KMT2ASMN1; SMN2RAB9A | |
| SCHEMBL16794816 | 0.84 | MAPT (0.71) | MAPTNPC1KMT2ASMN1; SMN2RAB9A | |
| SCHEMBL6206238 | 0.84 | SMN1; SMN2 (0.72) | MAPTNPC1KMT2ASMN1; SMN2RAB9A | |
| SCHEMBL16794802 | 0.84 | NPC1 (0.72) | MAPTNPC1KMT2ASMN1; SMN2RAB9A | |
| SCHEMBL8805009 | 0.84 | MAPT (1.00) | MAPTNPC1KMT2ASMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230389344-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2023-11-30 | — | — | US | disclosed |
| US-20230389344-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2023-11-30 | — | — | US | disclosed |
| US-10957865-B2 | Organic light emitting compound and organic light emitting diode including the same | SFC CO., LTD. (KR) | 2021-03-23 | — | — | US | disclosed |
| US-10957865-B2 | Organic light emitting compound and organic light emitting diode including the same | SFC CO., LTD. (KR) | 2021-03-23 | — | — | US | disclosed |
| US-20210057655-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME | SFC CO., LTD. (KR) | 2021-02-25 | — | — | US | disclosed |
| US-20210057655-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME | SFC CO., LTD. (KR) | 2021-02-25 | — | — | US | disclosed |
| EP-3275970-B1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME | SFC CO LTD (KR) | 2019-05-22 | — | — | EP | disclosed |
| EP-3275970-B1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME | SFC CO LTD (KR) | 2019-05-22 | — | — | EP | disclosed |
| US-20180040834-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME | SFC CO., LTD. (KR) | 2018-02-08 | — | — | US | disclosed |
| US-20180040834-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME | SFC CO., LTD. (KR) | 2018-02-08 | — | — | US | disclosed |
| WO-2011054844-A1 | CONDENSED AZEPINE DERIVATIVES AS BROMODOMAIN INHIBITORS | GLAXOSMITHKLINE LLC (US) | 2011-05-12 | — | — | WO | disclosed |
| WO-2011054844-A1 | CONDENSED AZEPINE DERIVATIVES AS BROMODOMAIN INHIBITORS | GLAXOSMITHKLINE LLC (US) | 2011-05-12 | — | — | WO | disclosed |
| US-20110098483-A1 | Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2011-04-28 | — | — | US | disclosed |
| US-20110098483-A1 | Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2011-04-28 | — | — | US | disclosed |
| US-20110098483-A1 | Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2011-04-28 | — | — | US | disclosed |
| WO-2009121033-A2 | SUBSTITUTED NITROGEN HETEROCYCLES AND SYNTHESIS AND USES THEREOF | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-10-01 | — | — | WO | disclosed |
| WO-2009121033-A2 | SUBSTITUTED NITROGEN HETEROCYCLES AND SYNTHESIS AND USES THEREOF | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-10-01 | — | — | WO | disclosed |
| US-20090247766-A1 | Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-10-01 | — | — | US | disclosed |
| US-20090247766-A1 | Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-10-01 | — | — | US | disclosed |
| US-20090247766-A1 | Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180040834-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME | HARS1, ALDH1A2, ALDH1A1 | MAPT 2672/4885NPC1 121/4885KMT2A 2916/4885 |
| US-20110098483-A1 | Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof | PAH, NAT1, NNT | MAPT 3189/4885NPC1 123/4885KMT2A 2793/4885 |
| US-20210057655-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME | HARS1, ALDH1A2, ALDH1A1 | MAPT 2672/4885NPC1 121/4885KMT2A 2916/4885 |
| US-20090247766-A1 | Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof | PAH, NAT1, NNT | MAPT 3189/4885NPC1 123/4885KMT2A 2793/4885 |
| US-10957865-B2 | Organic light emitting compound and organic light emitting diode including the same | HARS1, ALDH1A2, ALDH1A1 | MAPT 2735/4885NPC1 130/4885KMT2A 3006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.